| Literature DB >> 35114850 |
W Li1,2, X Huang1, W Yu1,3, Y Xu1, R Huang1, J Park1,3, A Moshaverinia4, P Arora5, C Chen1,6.
Abstract
Periodontal ligament derived stem cells (PDLSCs) are capable of differentiating into multiple cell types and inducing a promising immunomodulation for tissue regeneration and disease treatment. However, it is still challenging to develop a practical approach to activate endogenous stem cells for tissue self-healing and regeneration. In this study, transcriptome analysis reveals that resveratrol promotes PDLSC stemness through activation of stem cell, osteoprogenitor, and chondroprogenitor markers. Self-renewal and multipotent differentiation abilities are also improved in resveratrol-treated PDLSCs. In addition, immunomodulation of PDLSCs is dramatically increased after resveratrol treatment. Mechanistically, we show that resveratrol activates ERK/WNT crosstalk through elevation of olfactory and growth factor signaling pathways to upregulate the expression levels of RUNX2 and FASL for osteogenesis and immunomodulation, respectively. By using a periodontitis animal model, administration of resveratrol partially rescues bone loss through activation of endogenous somatic stem cells and inhibition of inflammatory T-cell infiltration. Taken together, our findings identify a novel pharmacological approach to achieve autotherapies for endogenous tissue regeneration.Entities:
Keywords: autotherapy; immunomodulation; periodontal ligament derived stem cells (PDLSCs); periodontitis; regenerative medicine; resveratrol
Mesh:
Substances:
Year: 2022 PMID: 35114850 PMCID: PMC9218498 DOI: 10.1177/00220345211070222
Source DB: PubMed Journal: J Dent Res ISSN: 0022-0345 Impact factor: 8.924